Viewing nowCombinationGavsmate Tablet 50/500 mg
Vildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.

MFDS item code 201206684 · Approved 2012.09.03 · Insurance code 653602300
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication helps control blood sugar levels in patients with type 2 diabetes by using vildagliptin and metformin together. It supports patients who are also managing their diet and exercising, enabling them to more effectively manage blood glucose levels. Improved blood sugar control aids in diabetes management and plays an important role in preventing complications.
For the treatment of patients with type 2 diabetes mellitus, the dose of this medication should be individualized based on efficacy and tolerability, without exceeding vildagliptin 100mg and metformin 2000mg. Vildagliptin doses above 100mg per day are not recommended. This medication is generally administered with or immediately after a meal to reduce gastrointestinal adverse reactions caused by metformin. 1. Patients with no previous experience of antidiabetic drug treatment who do not achieve adequate glycemic control with monotherapy: The initial dose is one tablet of this medication 50/500mg once daily; the dose may be gradually increased to one tablet of 50/1000mg twice daily. 2. Patients switching from combination therapy with vildagliptin and metformin: Patients switching from combination therapy with vildagliptin and metformin to this medication may start at their existing doses of vildagliptin and metformin. Studies have not been conducted to evaluate the safety and efficacy of switching from other oral antihyperglycemic agents to this medication. Any change in treatment for type 2 diabetes may affect glycemic control, so caution and appropriate monitoring are required. If a dose is missed, take it with the next meal unless it is not yet time for the missed dose; do not take twice the dose at once to make up for the missed dose. Patients with hepatic impairment This medication is not recommended for patients with clinical or laboratory evidence of hepatic impairment, including patients whose ALT or AST levels exceed 2.5 times the upper limit of normal, before starting treatment.
This medication can cause severe lactic acidosis or hypoglycemia, and should not be administered to patients at risk for these symptoms. It is especially contraindicated for patients with moderate to severe renal impairment, severe heart failure, or acute cardiac conditions and sepsis. Patients undergoing examinations using radiocontrast iodinated agents should discontinue use of this medication 48 hours prior to the exam and only resume after confirming normal renal function. This medication is not administered to patients with hypersensitivity to it, type 1 diabetes patients, or patients with diabetic ketoacidosis. Caution should be exercised when administering to patients with severe infections, trauma, pre- and post-surgery, malnutrition, liver dysfunction, pulmonary dysfunction, or excessive alcohol consumption. It is safest not to administer this medication to pregnant or breastfeeding women. Due to the risk of hypoglycemia, caution is advised in cases of irregular meals, intense exercise, or concurrent use of other blood sugar-lowering agents. During treatment, regular monitoring of liver and kidney function should be conducted, and any abnormalities should be reported to a physician immediately. If symptoms of acute pancreatitis occur, the medication should be stopped immediately and medical attention should be sought. Alcohol intake may increase the risk of side effects of this medication, so it is advisable to avoid drinking during treatment. Patients should be vigilant for symptoms of hypoglycemia and take appropriate action immediately if they occur. Elderly patients may have decreased renal function and require dose adjustment and regular monitoring of renal function. In the event of overdose, prompt medical attention should be sought, and hem dialysis may be necessary. Store this medication in a tightly closed container, out of reach of children, and do not transfer to another container. Particularly, this medication is not recommended for patients suspected of or diagnosed with mitochondrial diseases, and if any adverse symptoms occur, it should be discontinued immediately, and a diagnostic evaluation should be performed.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is also advisable to keep it in a cool place with a temperature below 30 degrees.
Bright yellow oval film-coated tablets
60 tablets (10 tablets/PTP packaging × 6)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Korea United Pharm, Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Ahn-Guk Pharmaceutical Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
AhnGuk NewPharm Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Sinphong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.